Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis
2022 · Leukemia · 62 citations
https://doi.org/10.1038/s41375-022-01637-7
M
Marek Hus
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
264
Papers
2.3K
Citations
23
h-index
49
i10-index
Marek Hus is an academic researcher from Medical University of Lublin. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Chronic Lymphocytic Leukemia Research & Protein Degradation and Inhibitors. The author has an h-index of 23, co-authored 225 publications.
ORCID: 0000-0002-9036-6625Papers by this author
worksThalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
2011 · Annals of Hematology · 60 citations
https://doi.org/10.1007/s00277-011-1276-2
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma
2004 · British Journal of Cancer · 15 citations
https://doi.org/10.1038/sj.bjc.6602225
Review New drugs in multiple myeloma – role of carfilzomib and pomalidomide
2014 · Współczesna Onkologia · 7 citations
https://doi.org/10.5114/wo.2014.40175
Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors
2020 · Advances in Medical Sciences · 2 citations
https://doi.org/10.1016/j.advms.2020.06.002
MM-557 DREAMM-7 Update: Subgroup Analyses From a Phase 3 Trial of Belantamab Mafodotin (Belamaf) + Bortezomib and Dexamethasone (BVd) vs Daratumumab, Bortezomib, and Dexamethasone (DVd) in Relapsed/Refractory Multiple Myeloma (RRMM)
2024 · Clinical Lymphoma Myeloma & Leukemia · 2 citations
https://doi.org/10.1016/s2152-2650(24)01705-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat